Scheiner, B., Roessler, D., Phen, S., Lim, M., Pomej, K., Pressiani, T., . . . Pinter, M. (2023). Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma. JHEP reports, 5(1), . https://doi.org/10.1016/j.jhepr.2022.100620
Chicago-Zitierstil (17. Ausg.)Scheiner, Bernhard, et al. "Efficacy and Safety of Immune Checkpoint Inhibitor Rechallenge in Individuals with Hepatocellular Carcinoma." JHEP Reports 5, no. 1 (2023). https://doi.org/10.1016/j.jhepr.2022.100620.
MLA-Zitierstil (9. Ausg.)Scheiner, Bernhard, et al. "Efficacy and Safety of Immune Checkpoint Inhibitor Rechallenge in Individuals with Hepatocellular Carcinoma." JHEP Reports, vol. 5, no. 1, 2023, https://doi.org/10.1016/j.jhepr.2022.100620.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.